2m 2m 2m 2m 2m 2m 2m
ALX ONCOLOGY (ALXO)
NASDAQ
$1.98+$0.005 (+0.25%)
Price as of Jul 13, 2026 7:46 PM EDT- $265.1MMarket Cap
- 320.22%1-Year Change
- BiotechnologyIndustry
ALX ONCOLOGY (ALXO)
$1.98+$0.005 (+0.25%)
ALXO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.97 | ||
Change | -$0.15 (-7.29%) | ||
Open | $2.08 | ||
High | $2.13 | ||
Low | $1.94 | ||
Previous Close | $2.13 | ||
Volume | 1,216,875 | ||
30-Day Average Volume | 2,236,125 | ||
1-Week Change | -10.05% | ||
1-Month Change | 24.68% | ||
1-Year Change | 320.22% | ||
3-Year Change | -72.29% | ||
5-Year Change | -96.40% | ||
Fundamentals | |||
Shares Outstanding | 134.6M | ||
Total Assets | $178.3M | ||
Market Cap | $265.1M | ||
Enterprise Value | $241.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$17.9M | ||
Free Cash Flow | -$18.7M | ||
EBIT | -$17.6M | ||
EBITDA | -$17.4M | ||
Net Working Capital | $125.4M | ||
EPS | -$0.17 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -12 | ||
PEG | -0 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue